Humana, Inc. Hits New 52-Week High at USD 369.25

Humana, Inc., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 369.25 on June 10, 2026. This achievement underscores the company's robust market position within the mid-cap sector, where it boasts a market capitalization of USD 32,156 million. Over the past year, Humana's stock has demonstrated a performance increase of 4.33%, although it trails behind the S&P 500's performance of 20.34%. The company's price-to-earnings (P/E) ratio stands at 27.00, reflecting its valuation relative to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to its shareholders. With a debt-to-equity ratio of -0.42, Humana maintains a strong balance sheet, while its return on equity is reported at 6.81%. The price-to-book ratio of 1.82 further indicates the company's valuation in relation to its assets. This recent high marks a notable point in Humana's financial journey, highlighting its ongoing performance in the competitive healthcare services landscape.